Opsoclonus-myoclonus syndrome after adenovirus infection
- PMID: 26543770
- PMCID: PMC4628014
- DOI: 10.1186/s40064-015-1429-1
Opsoclonus-myoclonus syndrome after adenovirus infection
Abstract
Autoimmune and paraneoplastic movement disorders are rare in childhood. Diagnosis often relies on clinical manifestations and clinicians' recognition. A 22-month-old girl at onset of opsoclonus-myoclonus syndrome (OMS) was followed for 8 years. Adenovirus (type C subtype 3) infection coincided with manifestation. Data on treatment, imaging and follow-up are provided. In the spinal fluid, elevated anti-rubella antibodies and oligoclonal bands were detected. An autoimmune process affecting mainly cerebellar neurons was revealed immunohistochemically. Moderately intense long-term immunosuppressive therapy resulted in a favorable clinical outcome. A video demonstrated severe OMS manifestations at onset, followed by nearly complete recovery after treatment. We describe the association of a parainfectious OMS and adenovirus infection; laboratory results indicate a non-specific humoral process affecting mainly cerebellar neurons. Our video documentation will aid to recognize this rare movement disorder and to initiate early treatment.
Keywords: Ataxia; Autoimmune; Children; Encephalopathy; Movement disorder.
Figures


References
-
- Denne C, Kleines M, Scheithauer S, Heimann G, Häusler M. Methotrexate: a new treatment in opsoclonus-myoclonus syndrome. J Pediatr Neurol. 2006;4:183–185.
-
- Hayward K, Jeremy RJ, Jenkins S, Barkovich AJ, Gultekin SH, Kramer J, Crittenden M, Matthay KK. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. J Pediatr. 2001;139:552–559. doi: 10.1067/mpd.2001.118200. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources